Development of tumor mutation burden as an immunotherapy biomarker: utility for the oncology clinic

Chan, T.A., Yarchoan, M., Jaffee, E.M., Swanton, C., Quezada, S.A., Stenzinger, A., &amp; Peters, S. (2018). Development of tumor mutation burden as an immunotherapy biomarker: utility for the oncology clinic. <em>Annals of Oncology</em>. https://doi.org/10.1093/annonc/mdy495

Chan TA, Yarchoan M, Jaffee EM, Swanton C, Quezada SA, Stenzinger A, et al. Development of tumor mutation burden as an immunotherapy biomarker: utility for the oncology clinic. Annals of Oncology. 2018. doi:10.1093/annonc/mdy495.

@article{timothy2018Develo, title = {Development of tumor mutation burden as an immunotherapy biomarker: utility for the oncology clinic}, author = {Timothy A. Chan and Mark Yarchoan and Elizabeth M. Jaffee and Charles Swanton and Sergio A. Quezada and Albrecht Stenzinger and Solange Peters}, journal = {Annals of Oncology}, year = {2018}, doi = {10.1093/annonc/mdy495}, }